C12Y 208/02
Sulfotransferases
Official title: Sulfotransferases (2.8.2)
C12Y208/02 (Sulfotransferases) appears on 69 US grants and 128 published applications in this corpus.
Search patents in C12Y- Granted patents
- 69
- Published applications
- 128
- Assignees
- 62
- Inventors
- 203
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 0 |
| 2011 | 2 | 3 |
| 2012 | 2 | 1 |
| 2013 | 1 | 3 |
| 2014 | 2 | 4 |
| 2015 | 1 | 4 |
| 2016 | 2 | 9 |
| 2017 | 2 | 4 |
| 2018 | 2 | 5 |
| 2019 | 5 | 10 |
| 2020 | 10 | 12 |
| 2021 | 5 | 12 |
| 2022 | 5 | 10 |
| 2023 | 16 | 15 |
| 2024 | 7 | 9 |
| 2025 | 4 | 12 |
| 2026 | 1 | 7 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 208/02015Steroid sulfotransferase14
- C12Y 208/02023[heparan sulfate]-glucosamine 3-sulfotransferase 112
- C12Y 208/02008[heparan sulfate]-glucosamine n-sulfotransferase11
- C12Y 208/02011Galactosylceramide sulfotransferase10
- C12Y 208/02001Aryl sulfotransferase9
- C12Y 208/0202Protein-tyrosine sulfotransferase4
- C12Y 208/02005Chondroitin 4-sulfotransferase1
- C12Y 208/02017Chondroitin 6-sulfotransferase1
All 34 subgroupsShow fewer
- C12Y 208/02029[heparan sulfate]-glucosamine 3-sulfotransferase 21
- C12Y 208/02033N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase1
- C12Y 208/02002Alcohol sulfotransferase0
- C12Y 208/02003Amine sulfotransferase0
- C12Y 208/02004Estrone sulfotransferase0
- C12Y 208/02006Choline sulfotransferase0
- C12Y 208/02007Udp-n-acetylgalactosamine-4-sulfate sulfotransferase0
- C12Y 208/02009Tyrosine-ester sulfotransferase0
- C12Y 208/0201Renilla-luciferin sulfotransferase0
- C12Y 208/02013Psychosine sulfotransferase0
- C12Y 208/02014Bile-salt sulfotransferase0
- C12Y 208/02016Thiol sulfotransferase0
- C12Y 208/02018Cortisol sulfotransferase0
- C12Y 208/02019Triglucosylalkylacylglycerol sulfotransferase0
- C12Y 208/02021Keratan sulfotransferase0
- C12Y 208/02022Aryl-sulfate sulfotransferase0
- C12Y 208/02024Desulfoglucosinolate sulfotransferase0
- C12Y 208/02025Flavonol 3-sulfotransferase0
- C12Y 208/02026Quercetin-3-sulfate 3'-sulfotransferase0
- C12Y 208/02027Quercetin-3-sulfate 4'-sulfotransferase0
- C12Y 208/02028Quercetin-3,3'-bissulfate 7-sulfotransferase0
- C12Y 208/0203[heparan sulfate]-glucosamine 3-sulfotransferase 30
- C12Y 208/02031Petromyzonol sulfotransferase0
- C12Y 208/02032Scymnol sulfotransferase0
- C12Y 208/02034Glycochenodeoxycholate sulfotransferase0
- C12Y 208/02035Dermatan 4-sulfotransferase0
Recent patents
- In vitro heparin and heparan sulfate compositions and methods of making and using26 May 2026US 12,636,307 B2TEGA Therapeutics, Inc.
- Delivery of gene therapy treatments26 Aug 2025US 12,397,066 B2Indiana University Research and Technology Corporation
- Compositions and methods for the treatment of alopecia5 Aug 2025US 12,377,098 B2Follea International
- Method for producing sulfated polysaccharide and method for producing PAPS1 Apr 2025US 12,264,350 B2Kirin Biomaterials Co., Ltd.
- Methods and compositions for protection against lentiviral infections28 Jan 2025US 12,209,113 B2University of Florida Research Foundation, Inc.
- Novel therapeutic agent for parkinson's disease8 Oct 2026US 2026/0308542 A1
- Novel biosynthesis system for producing 3'-phosphoadenosine-5'-phosphosulfate and application thereof8 Oct 2026US 2026/0308651 A1Jiangnan University
- Novel peptide derived from ndst3 or ndst4 having deacetylase or sulfotransferase activity23 Jul 2026US 2026/0209724 A1Korea Institute of Science and Technology
- Compositions and methods for treating acute respiratory distress syndrome18 Jun 2026US 2026/0166087 A1Direct Biologics, LLC
- Methods of Production of Heparosan, Heparan Sulfate and Heparin in Yeast18 Jun 2026US 2026/0168001 A1Genhtis Fine Chemicals GmbH
Most cited
By later US patents
- Immunogenic epitope for immunotherapy117US 8,080,634 B2Immatics Biotechnologies GmbH · 2011
- Immunogenic epitopes for immunotherapy113US 9,511,128 B2Immatics Biotechnologies GmbH · 2016
- Immunogenic epitopes for immunotherapy106US 8,669,230 B2Immatics Biotechnologies GmbH · 2014
- Immunogenic epitopes for immunotherapy106US 9,950,048 B2Immatics Biotechnologies GmbH · 2018
- Immunotherapy against neuronal and brain tumors53US 10,420,800 B2Immatics Biotechnologies GmbH · 2019